HIV – Global Clinical Trial Landscape

Explore the far-reaching impact of HIV, the latest global research priorities, and the innovative treatments, such as Antiretroviral therapy (ART), that offer hope in finding a cure. Gain insights from CRO experts, Novotech, on key topics, such as:

Clinical trial landscape
HIV vaccines and gene editing
Region-specific prevalence
Funding distribution

Sign up to our content service and access now

Your company email address

Please select your industry: (max 1)
Would you like to hear more from a Novotech expert about clinical trials?

Opt In?

By you requesting this resource, you agree to our terms of use. All data is protected by our Privacy Notice. You can change your contact preferences here. If you have any further questions please get in contact.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow Novotech to store and process the information submitted to provide you the content requested. They are subject to Novotech’s Terms and Conditions.

Immune checkpoint inhibitors: A breakthrough for immunotherapy

Immune checkpoint inhibitors (ICIs) have shown their efficacy, not only as a standalone treatment, but also when combined with traditional methods like chemotherapy and radiation. However, persistent challenges such as high costs and regulatory hurdles still exist. Gain expert knowledge on this novel approach to cancer therapy, with key topics including:

HIV – Global Clinical Trial Landscape

Sign up to our content service and access now

Opt In?

Explore similar content

Resiliency and innovation - Navigating the current biotech landscape

Immune checkpoint inhibitors: A breakthrough for immunotherapy

Incorporating Digital Biomarkers & Endpoints Into Clinical Trials: Key Regulatory Considerations